Zechen Wang
机构:Beijing Normal University, Guangdong University of Petrochemical Technology, Io Therapeutics (United States) · ORCID:0000-0003-4149-5903
发表论文 18 篇 · 总被引 375 次 · h-index 10
代表论文
- Strategy to Lengthen the On-Time of Photochromic Rhodamine Spirolactam for Super-resolution Photoactivated Localization Microscopy (2019 · Journal of the American Chemical Society · 被引 138)
- Dual functional cholinesterase and MAO inhibitors for the treatment of Alzheimer’s disease: synthesis, pharmacological analysis and molecular modeling of homoisoflavonoid derivatives (2015 · Journal of Enzyme Inhibition and Medicinal Chemistry · 被引 44)
- Discovery of boron-containing compounds as Aβ aggregation inhibitors and antioxidants for the treatment of Alzheimer's disease (2018 · MedChemComm · 被引 38)
- Therapeutic Targeting of FGFR Signaling in Head and Neck Cancer (2022 · The Cancer Journal · 被引 36)
- Leveraging patient derived models of FGFR2 fusion positive intrahepatic cholangiocarcinoma to identify synergistic therapies (2022 · npj Precision Oncology · 被引 20)
- Inhaled DNAI1 mRNA therapy for treatment of primary ciliary dyskinesia (2025 · Proceedings of the National Academy of Sciences · 被引 19)